- Home
- About Us
- Products
- Our Capabilities
- Services
- Contract Development and Manufacturing Organisation {CDMO)
- Contract Manufacturing (CMO]
- Contract Research (CRO)
- Custom Synthesis / Third— Party Manufacturing
- DMF Preparation
- Formulation Research & Development (FR&D)
- Global Marketing Representation
- Market Research & Business Intelligence
- Quality Control (QC) Auditing
- Strategic Marketing
- Supply Chain Management
- Technology Transfer & Scale Up
- Business Partners
- Contact Us
Racemic Dapoxetine Oxalate
API : Dapoxetine Hydrochloride
Racemic Methyl. Alpha.-(4,5,6,7-Tetrahydro-5-Thieno[3,2-C]Pyridyl) (2-Chlorophenyl)Acetate HCl (From Route-I)
API : Clopidogrel Bisulphate
Ractopamine
CAS NO : 97825-25-7
THERAPEUTIC CATEGORY : Beta-Adrenergic Agonists
Ractopamine Hydrochloride
CAS NO : 90274-24-1
THERAPEUTIC CATEGORY : Analgesics/Animal Feed Additive
Rafoxanide
CAS NO : 22662-39-1
THERAPEUTIC CATEGORY : Antiinfective
Raloxifene
CAS NO : 84449-90-1
THERAPEUTIC CATEGORY : Osteoporosis
Raloxifene Hydrochloride
CAS NO : 82640-04-08
THERAPEUTIC CATEGORY : Antiosteoporotic
Raltegravir
CAS NO : 871038-72-1
THERAPEUTIC CATEGORY : Antiretroviral
Raltegravir Potassium Form I
CAS NO : 871038-72-1
THERAPEUTIC CATEGORY : Antiretrovirals
Ramelteon
CAS NO : 196597-26-9
THERAPEUTIC CATEGORY : Insomnia
Ramipril
CAS NO : 87333-19-5
THERAPEUTIC CATEGORY : Cardiovascular/Antihypertensive
Ranitidine 150 / 300 Mg
CATEGORY : Gastroenterology
Ranitidine Hcl
CAS NO : 66357-35-5
THERAPEUTIC CATEGORY : Anti Ulcer
Ranitidine Hydrochloride Tablets IP 150 mg
CATEGORY : Anti-Ulcer
Ranitidine Pellets
USAGE : Anti Ulcerative
TYPE : Sustained Release /Controlled Release /Timed Release Pellets
Ranitidine Tablets IP 300 mg
CATEGORY : Anti-Ulcer
Ranolazine
CAS NO : 95635-55-5
THERAPEUTIC CATEGORY : Cardiovascular/Antihypertensive